Navigation Links
Bayer HealthCare and Health Alliance Medical Plans Enter Outcomes-based Agreement
Date:12/6/2011

S AND USAGE

BETASERON® (interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

IMPORTANT SAFETY INFORMATION

  • BETASERON should be used with caution in patients with depression.
  • Injection-site necrosis has been reported in 4% of patients in controlled trials. Patients should be advised of the importance of rotating injection sites.
  • Severe hepatic injury, including cases of hepatic failure, has been reported. Patients should be monitored for liver enzyme elevations while taking BETASERON.
  • BETASERON should be used with caution in patients with seizure disorders or cardiac disease.
  • Female patients should be warned about the potential risk to pregnancy.
  • Cases of anaphylaxis have been reported rarely.
  • The most commonly reported adverse reactions are lymphopenia (low numbers of a certain kind of white blood cell), injection-site reaction, asthenia (general weakness), flu-like symptom complex (flu syndrome and/or a combination of at least two Adverse Events from fever, chills, muscle aches, tiredness and sweating), headache and pain. Gradual dose titration and use of analgesics during treatment initiation may help reduce flu-like symptoms.

See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information. For important risk and use information, please see the full Prescribing Information. For more information about the Betaseron Pregnancy Registry, please visit

SOURCE Bayer HealthCare
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 Today, ... Inc. (NASDAQ: GILD ), Health Management Associates Inc. ... IDXX ), ISIS Pharmaceuticals Inc. (NASDAQ: ISIS ... access these reports free of charge - including full price ... below. Gilead Sciences, Inc. Research Report ...
(Date:6/18/2013)... 18, 2013 Apama Medical, a privately ... of next-generation atrial fibrillation technologies, today announced the ... US Patent and Trademark Office (USPTO), titled "Low ... assemblies for use on expandable structures such as ... procedures. "We are grateful to the ...
(Date:6/17/2013)... 17, 2013 Velplex, LLC announced this week ... platform that connects buyers and sellers of discount ... leader. Why? It,s because the business ... familiar with the dental industry. They have 50 years ... diligently worked to negotiate some of the best prices ...
Breaking Medicine Technology:Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6TopProdeals.com Rises to Top as Discount Dental Supply Leader 2
... SHENZHEN, China , April 30 ... or the "Company"), a leading manufacturer of,medical dressings, medical disposables and ... that it,closed its previously announced public offering of 1,380,000 shares of ... ...
... VIEW, Calif. , April 30 IRIDEX Corporation, (Nasdaq: ... 532 laser systems. The IQ 532 is a high-power, 532 nm, dual ... diseases such as diabetic retinopathy, age-related macular degeneration and glaucoma; and for ... , , ...
Cached Medicine Technology:Winner Medical Group Inc. Announces Closing of $8.4 Million Public Offering of Common Stock 2Winner Medical Group Inc. Announces Closing of $8.4 Million Public Offering of Common Stock 3Winner Medical Group Inc. Announces Closing of $8.4 Million Public Offering of Common Stock 4IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems 2
(Date:6/19/2013)... June 19, 2013 According to Vanessa ... abusers called “psychonauts” are creating new designer drugs featuring ... research of published documents and patented formulas. She reported ... & Now on June 4. , “Some of ... They’re never tested on humans. Maybe some of them ...
(Date:6/19/2013)... June 19, 2013 As more and ... want to use green energy-saving products to replace those ... of LED lights, produces a variety of products to ... bulbs, LED flood light, and LED spot lights ... light [ZT-D70-311F] is introduced to customers by Zhongtian Lighting ...
(Date:6/19/2013)... Fredericton, NB (PRWEB) June 19, 2013 ... Contact Center ACD for Asterisk, announced ... for Q-Suite 5.7. This enhancement offers improved options ... through web-based dashboards for effective contact center management. ... data in real-time captured as it happens from ...
(Date:6/19/2013)... Best Halfway House is stretching its sober housing ... keep on their road of recovery from drug and alcohol ... for sober houses for men and women. , The sober ... to meet certain criteria. They have to be clean and ... structure and accountability measures in place. This ensures residents are ...
(Date:6/19/2013)... 19, 2013 Pharmaceutical history is ... treat conditions with little or no understanding why ... biochemical processes involved emerging years later. When ... study demonstrating rapid recovery of cognitive functions after ... little was known about the role inflammatory processes ...
Breaking Medicine News(10 mins):Health News:Dangerous Designer Drugs Dodge Legal System 2Health News:Dangerous Designer Drugs Dodge Legal System 3Health News:3W High Power LED Down Light [ZT-D70-311F] Is Introduced to Customers by Zhongtian Lighting 2Health News:Indosoft Improves Q-Suite Real-time ACD Reporting to Enhance Contact Center Productivity 2Health News:Pensacola, Florida Joins Best Halfway House Recovery Network, Providing Resources for Those Seeking to Further Their Recovery from Drug and Alcohol Addiction 2Health News:Perispinally Administered Enbrel Facilitates Rapid Recovery of Cognitive Function in Patients with Alzheimer's 2
... , Feb. 1 Givers can double their ... The National Christian Foundation (NCF) at www.nationalchristian.com/haitirenewal . Thanks ... Haiti Renewal Fund will be matched dollar-for-dollar up to ... for rebuilding and renewing the country. For more information and ...
... , SANTA ANA, Calif. , Feb. ... announced that it has received and accepted subscriptions aggregating 2,000,000 shares ... the minimum offering amount required by the state of Ohio ... , About Grubb & Ellis Healthcare REIT II , ...
... the contrast agent gadolinium during magnetic resonance imaging (MRI) ... node metastases, according to a new study published online ... Cancer Institute . Gadolinium-enhanced MRI is primarily used to ... detect and evaluate lymph node metastases. In light of ...
... One of the holy grails of local anesthesia is the ... sensation while not affecting motor function. Now, researchers at Children,s ... do just that. If it proves to work in humans ... useful in a variety of medical applications, providing, for example, ...
... may someday improve prevention efforts , MONDAY, Feb. 1 (HealthDay ... a pregnant mouse leads to changes inside the uterus that ... fetus. , The findings, published online in the ... to prevent and treat premature birth, the study,s senior investigator, ...
... Featuring ... convert into a stylish, comfortable footrest , ... Las Vegas (PRWEB) February 1, 2010 -- Human Touch ... and other wellness solutions, announced today the introduction of its new and most advanced ...
Cached Medicine News:Health News:The National Christian Foundation Offers to Match Gifts to Haiti 2Health News:Grubb & Ellis Healthcare REIT II Meets Ohio's Minimum Offering 2Health News:News brief: Contrast agent with MRI improves detection of lymph nodes metastases 2Health News:Anesthetic approach stops pain without affecting motor function 2Health News:Human Touch Introduces New CirQlation™ Elite Foot & Calf Massager Providing Ultimate Targeted Relief for Tired Feet and Calves 2Health News:Human Touch Introduces New CirQlation™ Elite Foot & Calf Massager Providing Ultimate Targeted Relief for Tired Feet and Calves 3Health News:Human Touch Introduces New CirQlation™ Elite Foot & Calf Massager Providing Ultimate Targeted Relief for Tired Feet and Calves 4
... kit is an enzyme immunometric assay ... a liquid phase,incubation, designed for the ... The microplate is coated,with anti-rabbit antibodies.,Calibrators ... anti-rabbit antibody-coated wells, along with rabbit ...
Myoglobin RIA Lipid / Protein Quantification, Cardiovascular 024-IDC-11 Muscle Disease...
ACTH EIA Hypertension / Cardiac Evaluation, Cardiovascular 021-SDX018...
Anti-Gliadin IgG (Ab) EIA Gastrointestinal Markers 027-GD16 Celiac Disease Food Allergy...
Medicine Products: